Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Nature|May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencingVolker Hovestadt, David T W Jones, Simone Picelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation CohortMartin Mynarek, Katja von Hoff, Torsten Pietsch, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Acta Neuropathologica|November 23, 2013
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupNicholas G Gottardo, Jordan R Hansford, Jacqueline P McGlade, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Nature Medicine|March 17, 2023
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncologyDominik Sturm, David Capper, Felipe Andreiuolo, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Nature|May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencingVolker Hovestadt, David T W Jones, Simone Picelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation CohortMartin Mynarek, Katja von Hoff, Torsten Pietsch, et al.
Cancer Discovery|April 21, 2021
Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial EpendymomasTuyu Zheng, David R Ghasemi, Konstantin Okonechnikov, et al.
Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Neuro-Oncology|April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhoodCraig Erker, Martin Mynarek, Marie Simbozel, et al.
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Acta Neuropathologica|November 23, 2013
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working GroupNicholas G Gottardo, Jordan R Hansford, Jacqueline P McGlade, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Nature Medicine|March 17, 2023
Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncologyDominik Sturm, David Capper, Felipe Andreiuolo, et al.
Pageof 24